Iceland

Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial

Study of Efficacy and Safety of Investigational Treatments in Patients With Moderate to Severe Hidradenitis Suppurativa

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM

Efficacy and Safety Study of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment.

The Intensive Care Platform Trial

Culturally Adapted Materials to Increase Cervical Cancer Screening Among Polish Women in Iceland

An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects

Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer

A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)

Saroglitazar Magnesium for Treatment of Primary Biliary Cholangitis

bNAbs and Anti-PD-1 in HIV

OCD Summer Treatment Program for Adolescents in Iceland

Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD

Omega-Cold Supplementation With Free Fatty Acids for the Prevention of Respiratory Infections in Adults.

The ADHD Kids´ Study for Children 9-12 Years of Age

Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

A Treatment Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia

A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia